Evidera
Christopher Pelligra has an extensive work experience in the research field. Christopher started their career at Cornell University Annual Fund as a University Representative from October 2009 to May 2010. Christopher then joined Cornell University as a Student Assistant from July 2010 to March 2011. In August 2011, they became a Research Assistant at United Biosource Corporation until October 2012. Christopher joined Evidera in October 2012 as a Research Associate I and worked their way up to Senior Director, Research Science, their current role since February 2023. During their time at Evidera, they held various positions including Research Associate II from October 2013 to April 2014, Research Associate III from April 2014 to April 2016, Senior Research Associate from April 2016 to April 2018, and Research Scientist from April 2018 to January 2023.
Christopher Pelligra obtained a Bachelor of Arts (BA) degree in Mathematics from Cornell University, where they studied from 2007 to 2011. Christopher is currently pursuing a Master's degree in Economic Evaluation for Health Technology Assessment at the University of York, with an expected graduation year in 2022.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.